Lack of steady income can cause patients to face difficulties in bearing treatment costs that can reach up to RM40,000 a year ...

A recent study on kidney disease found that nearly half of patients with advanced chronic kidney disease (CKD) in the country ...

Lipid-lowering therapy has been well documented to effectively and safely reduce LDL cholesterol levels amongst CKD patients. The SHARP study has shown that lipid-lowering therapy will ...

A number of studies of primarily statin therapy in patients with pre-dialysis CKD have demonstrated their effectiveness at lowering LDL cholesterol. The UK-HARP studies (UK Heart and Renal ...

Skin infections like cellulitis can occur more frequently in people with CKD due to poor blood circulation and swelling in the legs The symptoms of infections may be less noticeable in people with ...

Semaglutide is now approved for T2D patients with CKD, reducing cardiovascular and kidney disease risks. The FLOW phase 3b trial showed significant reductions in adverse kidney and cardiovascular ...